Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Text messages empower HIV-positive women to take control of family planning

NCT ID NCT05285670

Disease control Sponsor: University of Washington Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests whether text messages and counseling can help women living with HIV make better decisions about contraception and pregnancy. About 3,310 women in Kenya will receive either standard care or the mobile health program. The goal is to reduce unplanned pregnancies and improve use of effective birth control methods.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

3,310 people

The number who actually took part.

Started

Dec 2022

Expected to finish

Jun 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

14 to 45 years

Sex

Female participants only

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * HIV-infected * Receiving HIV care at study site * Reproductive age (18-45; 14-17 if emancipated minors) * Daily access to mobile phone (own phone or shared) * Plan to receive HIV care at enrollment facility for 2 years * Speak English, Kiswahili, or Luo * Literate or comfortable with someone reading study SMS Exclusion Criteria: * Currently pregnant

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Contraception are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

AIDS HIV infectious disease infertility disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contraception Fertility issues HIV

Contacts and locations

Locations

  • Bondo sub-County Hospital

    Bondo, Kenya

  • Dandora 2 Health Center

    Nairobi, Kenya

  • Kangemi Health Centre

    Nairobi, Kenya

  • Kenyatta National Hospital

    Nairobi, Kenya

  • Kisumu District General Hospital

    Kisumu, Kenya

  • Lumumba sub-County Hospital

    Kisumu, Kenya

  • Mathare North Health Center

    Nairobi, Kenya

  • Rachuonyo District

    Oyugis, Kenya

  • Riruta Health Center

    Nairobi, Kenya

  • Siaya District Hospital

    Siaya, Kenya

More trials for these conditions

Other studies related to the condition(s) this trial covers.